Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy

Eur Heart J. 2005 Feb;26(3):210-2. doi: 10.1093/eurheartj/ehi077. Epub 2004 Dec 15.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Apolipoprotein A-I / blood*
  • Apolipoproteins B / blood*
  • Biomarkers / blood
  • Female
  • Humans
  • Hypolipidemic Agents / therapeutic use*
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnosis*
  • Risk Factors

Substances

  • Apolipoprotein A-I
  • Apolipoproteins B
  • Biomarkers
  • Hypolipidemic Agents